Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 361 to 370 of 370 entries
Sorted by: Best Match Show Resources per page
Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy.

Clinical and translational medicine

Moreau A, Reisqs JB, Delanoe-Ayari H, Pierre M, Janin A, Deliniere A, Bessière F, Meli AC, Charrabi A, Lafont E, Valla C, Bauer D, Morel E, Gache V, Millat G, Nissan X, Faucherre A, Jopling C, Richard S, Mejat A, Chevalier P.
PMID: 33784018
Clin Transl Med. 2021 Mar;11(3):e319. doi: 10.1002/ctm2.319.

BACKGROUND: Severe ventricular rhythm disturbances are the hallmark of arrhythmogenic cardiomyopathy (ACM), and are often explained by structural conduction abnormalities. However, comprehensive investigations of ACM cell electrical instability are lacking. This study aimed to elucidate early electrical myogenic signature...

Cite
Moreau A, Reisqs JB, Delanoe-Ayari H, et al. Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy. Clin Transl Med. 2021;11(3):e319doi: 10.1002/ctm2.319.
Moreau, A., Reisqs, J. B., Delanoe-Ayari, H., Pierre, M., Janin, A., Deliniere, A., Bessière, F., Meli, A. C., Charrabi, A., Lafont, E., Valla, C., Bauer, D., Morel, E., Gache, V., Millat, G., Nissan, X., Faucherre, A., Jopling, C., Richard, S., Mejat, A., & Chevalier, P. (2021). Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy. Clinical and translational medicine, 11(3), e319. https://doi.org/10.1002/ctm2.319
Moreau, Adrien, et al. "Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy." Clinical and translational medicine vol. 11,3 (2021): e319. doi: https://doi.org/10.1002/ctm2.319
Moreau A, Reisqs JB, Delanoe-Ayari H, Pierre M, Janin A, Deliniere A, Bessière F, Meli AC, Charrabi A, Lafont E, Valla C, Bauer D, Morel E, Gache V, Millat G, Nissan X, Faucherre A, Jopling C, Richard S, Mejat A, Chevalier P. Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy. Clin Transl Med. 2021 Mar;11(3):e319. doi: 10.1002/ctm2.319. PMID: 33784018; PMCID: PMC7908047.
Copy Download .nbib Format: NLM
Epithelial colonization by gut dendritic cells promotes their functional diversification.

Immunity

Rivera CA, Randrian V, Richer W, Gerber-Ferder Y, Delgado MG, Chikina AS, Frede A, Sorini C, Maurin M, Kammoun-Chaari H, Parigi SM, Goudot C, Cabeza-Cabrerizo M, Baulande S, Lameiras S, Guermonprez P, Reis E Sousa C, Lecuit M, Moreau HD, Helft J, Vignjevic DM, Villablanca EJ, Lennon-Duménil AM.
PMID: 34910930
Immunity. 2022 Jan 11;55(1):129-144.e8. doi: 10.1016/j.immuni.2021.11.008. Epub 2021 Dec 14.

Dendritic cells (DCs) patrol tissues and transport antigens to lymph nodes to initiate adaptive immune responses. Within tissues, DCs constitute a complex cell population composed of distinct subsets that can exhibit different activation states and functions. How tissue-specific cues...

Cite
Rivera CA, Randrian V, Richer W, et al. Epithelial colonization by gut dendritic cells promotes their functional diversification. Immunity. 2021;55(1):129-144.e8doi: 10.1016/j.immuni.2021.11.008.
Rivera, C. A., Randrian, V., Richer, W., Gerber-Ferder, Y., Delgado, M. G., Chikina, A. S., Frede, A., Sorini, C., Maurin, M., Kammoun-Chaari, H., Parigi, S. M., Goudot, C., Cabeza-Cabrerizo, M., Baulande, S., Lameiras, S., Guermonprez, P., Reis E Sousa, C., Lecuit, M., Moreau, H. D., Helft, J., Vignjevic, D. M., Villablanca, E. J., & Lennon-Duménil, A. M. (2022). Epithelial colonization by gut dendritic cells promotes their functional diversification. Immunity, 55(1), 129-144.e8. https://doi.org/10.1016/j.immuni.2021.11.008
Rivera, Claudia A, et al. "Epithelial colonization by gut dendritic cells promotes their functional diversification." Immunity vol. 55,1 (2022): 129-144.e8. doi: https://doi.org/10.1016/j.immuni.2021.11.008
Rivera CA, Randrian V, Richer W, Gerber-Ferder Y, Delgado MG, Chikina AS, Frede A, Sorini C, Maurin M, Kammoun-Chaari H, Parigi SM, Goudot C, Cabeza-Cabrerizo M, Baulande S, Lameiras S, Guermonprez P, Reis E Sousa C, Lecuit M, Moreau HD, Helft J, Vignjevic DM, Villablanca EJ, Lennon-Duménil AM. Epithelial colonization by gut dendritic cells promotes their functional diversification. Immunity. 2022 Jan 11;55(1):129-144.e8. doi: 10.1016/j.immuni.2021.11.008. Epub 2021 Dec 14. PMID: 34910930; PMCID: PMC8751639.
Copy Download .nbib Format: NLM
Case Report: Aperiodic Fluctuations of Neural Activity in the Ictal MEG of a Child With Drug-Resistant Fronto-Temporal Epilepsy.

Frontiers in human neuroscience

van Heumen S, Moreau JT, Simard-Tremblay E, Albrecht S, Dudley RW, Baillet S.
PMID: 33746727
Front Hum Neurosci. 2021 Mar 04;15:646426. doi: 10.3389/fnhum.2021.646426. eCollection 2021.

Successful surgical treatment of patients with focal drug-resistant epilepsy remains challenging, especially in cases for which it is difficult to define the area of cortex from which seizures originate, the seizure onset zone (SOZ). Various diagnostic methods are needed...

Cite
van Heumen S, Moreau JT, Simard-Tremblay E, et al. Case Report: Aperiodic Fluctuations of Neural Activity in the Ictal MEG of a Child With Drug-Resistant Fronto-Temporal Epilepsy. Front Hum Neurosci. 2021;15:646426doi: 10.3389/fnhum.2021.646426.
van Heumen, S., Moreau, J. T., Simard-Tremblay, E., Albrecht, S., Dudley, R. W., & Baillet, S. (2021). Case Report: Aperiodic Fluctuations of Neural Activity in the Ictal MEG of a Child With Drug-Resistant Fronto-Temporal Epilepsy. Frontiers in human neuroscience, 15646426. https://doi.org/10.3389/fnhum.2021.646426
van Heumen, Saskia, et al. "Case Report: Aperiodic Fluctuations of Neural Activity in the Ictal MEG of a Child With Drug-Resistant Fronto-Temporal Epilepsy." Frontiers in human neuroscience vol. 15 (2021): 646426. doi: https://doi.org/10.3389/fnhum.2021.646426
van Heumen S, Moreau JT, Simard-Tremblay E, Albrecht S, Dudley RW, Baillet S. Case Report: Aperiodic Fluctuations of Neural Activity in the Ictal MEG of a Child With Drug-Resistant Fronto-Temporal Epilepsy. Front Hum Neurosci. 2021 Mar 04;15:646426. doi: 10.3389/fnhum.2021.646426. eCollection 2021. PMID: 33746727; PMCID: PMC7969518.
Copy Download .nbib Format: NLM
Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors.

European journal of drug metabolism and pharmacokinetics

Jouan E, Moreau A, Bruyere A, Alim K, Denizot C, Parmentier Y, Fardel O.
PMID: 34275128
Eur J Drug Metab Pharmacokinet. 2021 Sep;46(5):625-635. doi: 10.1007/s13318-021-00703-2. Epub 2021 Jul 18.

BACKGROUND AND OBJECTIVES: Equilibrative nucleoside transporter (ENT) 1 is a widely-expressed drug transporter, handling nucleoside analogues as well as endogenous nucleosides. ENT1 has been postulated to be inhibited by some marketed tyrosine kinase inhibitors (TKIs). To obtain insights into...

Cite
Jouan E, Moreau A, Bruyere A, et al. Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors. Eur J Drug Metab Pharmacokinet. 2021;46(5):625-635doi: 10.1007/s13318-021-00703-2.
Jouan, E., Moreau, A., Bruyere, A., Alim, K., Denizot, C., Parmentier, Y., & Fardel, O. (2021). Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors. European journal of drug metabolism and pharmacokinetics, 46(5), 625-635. https://doi.org/10.1007/s13318-021-00703-2
Jouan, Elodie, et al. "Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors." European journal of drug metabolism and pharmacokinetics vol. 46,5 (2021): 625-635. doi: https://doi.org/10.1007/s13318-021-00703-2
Jouan E, Moreau A, Bruyere A, Alim K, Denizot C, Parmentier Y, Fardel O. Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors. Eur J Drug Metab Pharmacokinet. 2021 Sep;46(5):625-635. doi: 10.1007/s13318-021-00703-2. Epub 2021 Jul 18. PMID: 34275128; PMCID: PMC8286641.
Copy Download .nbib Format: NLM
[Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Bulletin du cancer

Paul F, Vicente C, Courbon C, Moreau AS, Picard M, Pochon C, Sterin A, Tudesq JJ, Yakoub-Agha M, Bay JO, Yakoub-Agha I.
PMID: 34876272
Bull Cancer. 2021 Dec 04; doi: 10.1016/j.bulcan.2021.11.001. Epub 2021 Dec 04.

Infections occurring after CAR T-cells are a common complication. At the acute phase of treatment following CAR T-cell infusion, the exact incidence of infections is unknown given the overlapping symptoms with cytokine release syndrome. The risk factors for infection...

Cite
Paul F, Vicente C, Courbon C, et al. Prise en charge prophylactique, thérapeutique des complications infectieuses et vaccination des patients traités par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). [Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer. 2021;doi: 10.1016/j.bulcan.2021.11.001.
Paul, F., Vicente, C., Courbon, C., Moreau, A. S., Picard, M., Pochon, C., Sterin, A., Tudesq, J. J., Yakoub-Agha, M., Bay, J. O., & Yakoub-Agha, I. (2021). Prise en charge prophylactique, thérapeutique des complications infectieuses et vaccination des patients traités par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). [Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bulletin du cancer, . https://doi.org/10.1016/j.bulcan.2021.11.001
Paul, Franciane, et al. "Prise en charge prophylactique, thérapeutique des complications infectieuses et vaccination des patients traités par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)." [Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bulletin du cancer vol. (2021). doi: https://doi.org/10.1016/j.bulcan.2021.11.001
Paul F, Vicente C, Courbon C, Moreau AS, Picard M, Pochon C, Sterin A, Tudesq JJ, Yakoub-Agha M, Bay JO, Yakoub-Agha I. Prise en charge prophylactique, thérapeutique des complications infectieuses et vaccination des patients traités par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). [Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer. 2021 Dec 04; doi: 10.1016/j.bulcan.2021.11.001. Epub 2021 Dec 04. French. PMID: 34876272.
Copy Download .nbib Format: NLM
Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2.

Science immunology

Harly C, Joyce SP, Domblides C, Bachelet T, Pitard V, Mannat C, Pappalardo A, Couzi L, Netzer S, Massara L, Obre E, Hawchar O, Lartigue L, Claverol S, Cano C, Moreau JF, Mahouche I, Soubeyran I, Rossignol R, Viollet B, Willcox CR, Mohammed F, Willcox BE, Faustin B, Déchanet-Merville J.
PMID: 34330813
Sci Immunol. 2021 Jul 30;6(61). doi: 10.1126/sciimmunol.aba9010.

Human γδ T cells contribute to tissue homeostasis and participate in epithelial stress surveillance through mechanisms that are not well understood. Here, we identified ephrin type-A receptor 2 (EphA2) as a stress antigen recognized by a human Vγ9Vδ1 TCR....

Cite
Harly C, Joyce SP, Domblides C, et al. Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2. Sci Immunol. 2021;6(61)doi: 10.1126/sciimmunol.aba9010.
Harly, C., Joyce, S. P., Domblides, C., Bachelet, T., Pitard, V., Mannat, C., Pappalardo, A., Couzi, L., Netzer, S., Massara, L., Obre, E., Hawchar, O., Lartigue, L., Claverol, S., Cano, C., Moreau, J. F., Mahouche, I., Soubeyran, I., Rossignol, R., Viollet, B., Willcox, C. R., Mohammed, F., Willcox, B. E., Faustin, B., & Déchanet-Merville, J. (2021). Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2. Science immunology, 6(61), . https://doi.org/10.1126/sciimmunol.aba9010
Harly, Christelle, et al. "Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2." Science immunology vol. 6,61 (2021). doi: https://doi.org/10.1126/sciimmunol.aba9010
Harly C, Joyce SP, Domblides C, Bachelet T, Pitard V, Mannat C, Pappalardo A, Couzi L, Netzer S, Massara L, Obre E, Hawchar O, Lartigue L, Claverol S, Cano C, Moreau JF, Mahouche I, Soubeyran I, Rossignol R, Viollet B, Willcox CR, Mohammed F, Willcox BE, Faustin B, Déchanet-Merville J. Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2. Sci Immunol. 2021 Jul 30;6(61). doi: 10.1126/sciimmunol.aba9010. PMID: 34330813.
Copy Download .nbib Format: NLM
A potential role of preexisting inflammation in the development of acute myelopathy following CAR T-cell therapy for diffuse large B-cell lymphoma.

Current research in translational medicine

Beauvais D, Cozzani A, Blaise AS, Moreau AS, Varlet P, Gaggero S, Alidjinou EK, Vannod-Michel Q, Morschhauser F, Labalette M, Yakoub-Agha I, Mitra S.
PMID: 34999480
Curr Res Transl Med. 2022 Jan 06;70(2):103331. doi: 10.1016/j.retram.2021.103331. Epub 2022 Jan 06.

The event of anti-CD19 chimeric antigen receptor (CAR)-T therapy inducing serious neurotoxicity in patients with diffuse large B-cell lymphoma (DLBCL) is recognized; however, the patterns of symptoms and severity vary greatly from patient to patient. We report an exceptional...

Cite
Beauvais D, Cozzani A, Blaise AS, et al. A potential role of preexisting inflammation in the development of acute myelopathy following CAR T-cell therapy for diffuse large B-cell lymphoma. Curr Res Transl Med. 2022;70(2):103331doi: 10.1016/j.retram.2021.103331.
Beauvais, D., Cozzani, A., Blaise, A. S., Moreau, A. S., Varlet, P., Gaggero, S., Alidjinou, E. K., Vannod-Michel, Q., Morschhauser, F., Labalette, M., Yakoub-Agha, I., & Mitra, S. (2022). A potential role of preexisting inflammation in the development of acute myelopathy following CAR T-cell therapy for diffuse large B-cell lymphoma. Current research in translational medicine, 70(2), 103331. https://doi.org/10.1016/j.retram.2021.103331
Beauvais, David, et al. "A potential role of preexisting inflammation in the development of acute myelopathy following CAR T-cell therapy for diffuse large B-cell lymphoma." Current research in translational medicine vol. 70,2 (2022): 103331. doi: https://doi.org/10.1016/j.retram.2021.103331
Beauvais D, Cozzani A, Blaise AS, Moreau AS, Varlet P, Gaggero S, Alidjinou EK, Vannod-Michel Q, Morschhauser F, Labalette M, Yakoub-Agha I, Mitra S. A potential role of preexisting inflammation in the development of acute myelopathy following CAR T-cell therapy for diffuse large B-cell lymphoma. Curr Res Transl Med. 2022 Jan 06;70(2):103331. doi: 10.1016/j.retram.2021.103331. Epub 2022 Jan 06. PMID: 34999480.
Copy Download .nbib Format: NLM
[Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Bulletin du cancer

Paul F, Vicente C, Courbon C, Moreau AS, Picard M, Pochon C, Sterin A, Tudesq JJ, Yakoub-Agha M, Bay JO, Yakoub-Agha I.
PMID: 34876272
Bull Cancer. 2021 Dec;108(12):S90-S97. doi: 10.1016/j.bulcan.2021.11.001. Epub 2021 Dec 06.

Infections occurring after CAR T-cells are a common complication. At the acute phase of treatment following CAR T-cell infusion, the exact incidence of infections is unknown given the overlapping symptoms with cytokine release syndrome. The risk factors for infection...

Cite
Paul F, Vicente C, Courbon C, et al. Prise en charge prophylactique, thérapeutique des complications infectieuses et vaccination des patients traités par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). [Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer. 2021;108(12):S90-S97doi: 10.1016/j.bulcan.2021.11.001.
Paul, F., Vicente, C., Courbon, C., Moreau, A. S., Picard, M., Pochon, C., Sterin, A., Tudesq, J. J., Yakoub-Agha, M., Bay, J. O., & Yakoub-Agha, I. (2021). Prise en charge prophylactique, thérapeutique des complications infectieuses et vaccination des patients traités par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). [Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bulletin du cancer, 108(12), S90-S97. https://doi.org/10.1016/j.bulcan.2021.11.001
Paul, Franciane, et al. "Prise en charge prophylactique, thérapeutique des complications infectieuses et vaccination des patients traités par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)." [Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bulletin du cancer vol. 108,12 (2021): S90-S97. doi: https://doi.org/10.1016/j.bulcan.2021.11.001
Paul F, Vicente C, Courbon C, Moreau AS, Picard M, Pochon C, Sterin A, Tudesq JJ, Yakoub-Agha M, Bay JO, Yakoub-Agha I. Prise en charge prophylactique, thérapeutique des complications infectieuses et vaccination des patients traités par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). [Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer. 2021 Dec;108(12):S90-S97. doi: 10.1016/j.bulcan.2021.11.001. Epub 2021 Dec 06. French. PMID: 34876272.
Copy Download .nbib Format: NLM
Children's art in health professions education.

The clinical teacher

Moreau KA, Eady K.
PMID: 33840157
Clin Teach. 2021 Oct;18(5):477-478. doi: 10.1111/tct.13353. Epub 2021 Apr 10.

No abstract available.

Cite
Moreau KA, Eady K. Children's art in health professions education. Clin Teach. 2021;18(5):477-478doi: 10.1111/tct.13353.
Moreau, K. A., & Eady, K. (2021). Children's art in health professions education. The clinical teacher, 18(5), 477-478. https://doi.org/10.1111/tct.13353
Moreau, Katherine A, and Eady, Kaylee. "Children's art in health professions education." The clinical teacher vol. 18,5 (2021): 477-478. doi: https://doi.org/10.1111/tct.13353
Moreau KA, Eady K. Children's art in health professions education. Clin Teach. 2021 Oct;18(5):477-478. doi: 10.1111/tct.13353. Epub 2021 Apr 10. PMID: 33840157.
Copy Download .nbib Format: NLM
A NOVEL NOX/PHOX-CD38-NAADP-TFEB AXIS IMPORTANT FOR MACROPHAGE ACTIVATION DURING BACTERIAL PHAGOCYTOSIS.

Autophagy

Najibi M, Honwad HH, Moreau JA, Becker SM, Irazoqui JE.
PMID: 33818279
Autophagy. 2021 Apr 13;1-18. doi: 10.1080/15548627.2021.1911548. Epub 2021 Apr 13.

Macrophage activation in the presence of bacterial cells and molecules entails complex programs of gene expression. How such triggers elicit specific gene expression programs is incompletely understood. We previously discovered that TFEB (transcription factor EB) is a key contributor...

Cite
Najibi M, Honwad HH, Moreau JA, et al. A NOVEL NOX/PHOX-CD38-NAADP-TFEB AXIS IMPORTANT FOR MACROPHAGE ACTIVATION DURING BACTERIAL PHAGOCYTOSIS. Autophagy. 2021;1-18doi: 10.1080/15548627.2021.1911548.
Najibi, M., Honwad, H. H., Moreau, J. A., Becker, S. M., & Irazoqui, J. E. (2021). A NOVEL NOX/PHOX-CD38-NAADP-TFEB AXIS IMPORTANT FOR MACROPHAGE ACTIVATION DURING BACTERIAL PHAGOCYTOSIS. Autophagy, 1-18. https://doi.org/10.1080/15548627.2021.1911548
Najibi, Mehran, et al. "A NOVEL NOX/PHOX-CD38-NAADP-TFEB AXIS IMPORTANT FOR MACROPHAGE ACTIVATION DURING BACTERIAL PHAGOCYTOSIS." Autophagy vol. (2021): 1-18. doi: https://doi.org/10.1080/15548627.2021.1911548
Najibi M, Honwad HH, Moreau JA, Becker SM, Irazoqui JE. A NOVEL NOX/PHOX-CD38-NAADP-TFEB AXIS IMPORTANT FOR MACROPHAGE ACTIVATION DURING BACTERIAL PHAGOCYTOSIS. Autophagy. 2021 Apr 13;1-18. doi: 10.1080/15548627.2021.1911548. Epub 2021 Apr 13. PMID: 33818279.
Copy Download .nbib Format: NLM
Showing 361 to 370 of 370 entries